Important note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.

Reuters NewMedia - December 6, 2008
Adam Cox

Luc Montagnier, director of the World Foundation for AIDS Research and Prevention, told a news conference together with this year's other winners for medicine that halting the transmission of AIDS would make it a disease much like others.

"Our job, of course, is to find complementary treatment to eradicate the infection. I think it's not impossible to do it within a few years," Montagnier said.

"So I hope to see in my lifetime the eradication of, not the AIDS epidemic, but at least the infection," the 76-year-old said. "This could be achieved."

Montagnier and Francoise Barre-Sinoussi, of the Institut Pasteur, shared half of the 2008 prize for discovering the virus that has killed 25 million people since the early 1980s.

There is no cure for AIDS, which infects an estimated 33 million globally, but cocktails of drugs can control the virus and keep patients healthy.

There is no vaccine either, although researchers are trying to find vaccines that either prevent infection or would control the virus so that patients are less likely to transmit it -- a so-called therapeutic vaccine.

Montagnier said he hoped such a therapeutic vaccine could be developed within about four to five years, noting he and colleagues had already been working on this for a decade.

German scientist Harald zur Hausen of the University of Duesseldorf won the other half of the 10-million-Swedish-crown ($1.2 million) award for finding the cause of cervical cancer.

The three scientists said that since the announcement in early October they had found themselves constantly giving interviews and speaking with world leaders.

"There's obviously a belief in many of the politicians and some other people ... that you know everything, which of course is nonsense. But in a way indeed I think one cannot ignore this," zur Hausen said.

Barre-Sinoussi, who had come from Senegal following a meeting with the African country's president, agreed.

"Of course I have the same feeling. I think I feel that we have responsibility to try to influence, especially, the politicians."

She feared the global financial crisis could lead some countries to water down their commitment to the fight against diseases such as AIDS, tuberculosis or malaria, so it was important Nobel winners tried to use their influence.

The three are in Stockholm for "Nobel Week," when laureates come to the Swedish capital for a barrage of news conferences, interviews and events, culminating with a gala dinner which this year takes place on Wednesday.

Montagnier and Barre-Sinoussi expected to use the prize money to further their research. They also said the award was important in that it shed a bright light on the issue of AIDS.

"Still, 25 years after the HIV discovery, (there is) discrimination, stigmatization against HIV-infected individuals, even criminalization. This is not acceptable. This is really not acceptable," Barre-Sinoussi said.

(Additional reporting by Maggie Fox in Washington; editing by Michael Roddy and Keith Weir)

081206
RE081210

Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .